AffiPATH®​ Breast cancer tissue array (most of triple negative) including pathology grade, TNM, clinical stage

Triple negative breast carcinoma and normal tissue microarray, containing 110 cases breast carcinoma with ER, PR and Her-2 all negative, 2 each of breast carcinoma with ER+, PR+ and Her-2+, (among them 95 cases invasive carcinoma of no special type, 1 each of invasive lobular carcinoma, neuroendocrine carcinoma, aggressive adenocarcinoma and mucinous adenocarcinoma, 8 medullary carcinoma, 2 each of carcinoid and micropapillary carcinoma, 5 mixed cancer), plus 4 breast tissue, single core per case